ProShares Ultra Health Care
20 hedge funds and large institutions have $9.78M invested in ProShares Ultra Health Care in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
0.75% less ownership
Funds ownership: 23.16% → 22.41% (-0.75%)
16% less capital invested
Capital invested by funds: $11.6M → $9.78M (-$1.85M)
17% less funds holding
Funds holding: 24 → 20 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $231K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$785K |
| 2 |
IMC Chicago
Chicago,
Illinois
|
+$636K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$76.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$72.3K |
| 5 |
PFA
Plotkin Financial Advisors
Chevy Chase,
Maryland
|
+$36.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$1.5M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$463K |
| 3 |
Jane Street
New York
|
-$120K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$61.6K |
| 5 |
First Manhattan
New York
|
-$22K |
RXL Hedge Fund Activity: Q3 2022 in Review
20 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q3 2022, worth a combined $9.78M — down 16% from $11.6M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of RXL and 0 opened new positions — a net loss of 4 holders — while 7 trimmed existing stakes and 7 added.
The largest buyer was Citadel Advisors, adding an estimated $785K. The largest seller was Old Mission Capital, cutting an estimated $1.5M.
- 20 institutional investors held ProShares Ultra Health Care (RXL) as of Q3 2022, down from 24 in Q2 2022.
- Funds reported $9.78M of ProShares Ultra Health Care stock for Q3 2022, down 16% quarter-over-quarter.
- 0 funds opened new ProShares Ultra Health Care positions in Q3 2022 and 4 closed out, a net change of -4 holders.
- The largest ProShares Ultra Health Care buyer in Q3 2022 was Citadel Advisors, an estimated $785K added.
- The largest ProShares Ultra Health Care seller in Q3 2022 was Old Mission Capital, an estimated $1.5M sold.
Based on aggregated 13F filings for Q3 2022.